Maytenus senegalensis is an important medicinal plant in East Africa. Methanolic extracts of the root-bark exhibit antibacterial activity. The isolation of the antibacterial compound, 3-oxo-friedelan-20α-oic acid, more commonly known as maytenonic acid, from the root-bark of M. senegalensis is described herein. This compound was first described in 1971 but the structure was not completely settled upon. The configuration at C-20 was corrected on the basis of chemical transformation and X-ray data of its methyl ester. Using improved NMR techniques a full set of spectral data for this compound is now given and configuration at C-20 confirmed by NOE contacts observed in 2D-ROESY spectrum.
Introduction
Maytenus senegalensis (Lam.) Excell (Celastraceae) is an important plant used in traditional medicine in East Africa. Habitually, Maytenus species are either trees or shrubs, growing to a height of 1-9 m (Robson et al., 1994) . The use of M. senegalensis in treating a variety of ailments is widely documented in the literature and includes pneumonia, tuberculosis, sore throat, earache, eye infections, rheumatism and venereal diseases (Watt and Breyer-Brandwijk, 1962; Kokwaro, 1976; Gachathi, 1989; Roodt, 1998; Van Wyk et al., 2000) . The roots are mostly used in preparing traditional remedies. Leaves and stem-bark are also used, but less frequently.
The bioactivity in Maytenus species has been attributed to various groups of secondary metabolites such as triterpenes and several types of alkaloids (Hutchings et al., 1996) . Most of the work described in the literature has concentrated on species other than M. senegalensis, which has received little attention (Kupchan et al., 1977; Brüning and Wagner, 1978; Shirota et al., 1996) . In vitro antiplasmodial activity of M. senegalensis root and stem bark have been reported (Gessler et al., 1994; El Tahir et al., 1999) . In vivo antiplasmodial activity was found in extracts of M. senegalensis (Gessler et al., 1995) and pristemerin, a pentacyclic triterpene of the friedelane type was reported to be responsible for this activity (El Tahir et al., 2001 ). In vitro antileishmanial activity (El Tahir et al., 2001 ) and moderate effects against HIV-1 protease (Hussein et al., 1999 ) is exhibited by stem-bark extracts. Maytenonic acid, 3-oxofriedelan-20α-oic acid, was first isolated from M. senegalensis by Abraham et al. (1971) . This compound was later isolated from the roots of Plenckia polpunea and named polpunonic acid, which has antibacterial and antimitotic activity (Monache et al., 1972) , and from the bark of Gymnosporia emarginata (Ramaiah et al., 1984) . Matu and van Staden (2003) investigated the activity of extracts of M. senegalensis for anti-inflammatory (COX-1) and antibacterial activity (agar diffusion) and reported that methanolic extracts of root and stem-bark exhibited the greatest activity in the agar diffusion assay whilst, methanolic extracts of root-bark, stem-bark and leaves exhibited good activity in the COX-1 assay.
The isolation and structure elucidation of the compound 3-oxo-friedelan-20α-oic acid (Scheme 1) responsible for antibacterial activity of the root-bark of M. senegalensis is described herein. The new complete set of proton chemical shifts and correction of some previously assigned carbon signals (Ramaiah et al., 1984) has now been achieved.
Materials and methods

Collection of plant material
Root-bark of M. senegalensis was collected from natural populations in the Central and Eastern provinces of Kenya. Mr. Onesmus Mwangani and Mr. Joshua Muasya of the East African Herbarium, Nairobi, Kenya, confirmed the botanical identification of the collected material. Voucher specimens were deposited in this herbarium and given the number ENM01EA.
The root-bark was cut into small pieces and dried at room temperature for a period of two weeks and then ground into a fine powder. The powder was sealed in an airtight bag in the dark at room temperature until extraction.
Bulk extraction
Powdered root-bark (300 g) was extracted with 2 l methanol by sonication in an ultra-sound bath for 30 min and left to macerate overnight. The extract was filtered through a Buchner funnel and Whatman No. 1 filter paper. The residue was reextracted twice, with 1.5 l of methanol each time. Filtration was repeated and the solvent evaporated under reduced pressure at 40°C yielding an oily, dark residue (85 g).
Isolation of antibacterial compounds by bioassay-guided fractionation
Thirty grams of the resultant methanolic extract were dissolved in 500 ml of distilled water and partitioned with 400 ml of ethyl acetate in a 2 l separating funnel. The funnel was agitated and the ethyl acetate layer removed. This was repeated three times. The resultant ethyl acetate and aqueous fractions were evaporated to dryness under reduced pressure. These fractions were tested for antibacterial activity in the antibacterial microtitre plate bioassay (Eloff, 1998) .
Residue from the ethyl acetate fraction (7 g) was fractionated by vacuum liquid chromatography (VLC) over silica gel (Merck 230-400 mesh) and eluted with a hexane-ethyl acetate gradient, starting at 100% hexane, decreasing to 85% and then further decreasing in steps of 5% per fraction to 60%. Thereafter, the percentage hexane was decreased by 10% in each fraction. The column was finally rinsed with methanol. Four hundred millilitres of solvent mixture were used per fraction. Each fraction was evaporated to dryness under reduced pressure and the yield determined. Aliquots of each fraction (250 μg) were loaded onto two separate TLC plates (Merck silica gel 60 F 254 , 0.25 mm) and developed in a hexaneethyl acetate 3 : 2 solvent system. One plate was stained with p-anisaldehyde (465 ml ethanol, 5 ml glacial acetic acid, 13 ml concentrated sulphuric acid, 13 ml p-anisaldehyde) and heated in an oven at 110°C for 10 min. Bioautography was used to assess antibacterial activity of the fractions obtained from VLC.
One of the fractions which exhibited antibacterial activity was eluted from the VLC column with a hexane-ethyl acetate mixture (70 : 30) and labelled fraction E. This was loaded onto five separate TLC plates (0.25 mm) and developed in a hexaneethyl acetate (3 : 2) solvent system. A strip approximately 2.5 cm wide was cut from one chromatogram using a diamond knife, and visualised with p-anisaldehyde stain. The stained portion was re-evaluated alongside untreated plates and the band corresponding to the yellow band on the stained plate was scraped and recovered from the plates. The Rf value for this band was calculated to be 0.64. The sample was filtered through 0.22 μm Millipore filter and taken to dryness yielding 5.7 mg. The minimum inhibitory concentration (MIC) was determined using the antibacterial microtitre plate bioassay and taken to be the lowest concentration of plant extract in wells in which colour change did not occur. Chemical structure of the active compound was determined from the detailed NMR analysis and GC-MS data. NMR spectra were measured on a Bruker AVANCE-500 apparatus ( 1 H at 500 MHz, 13 C at 125.77 MHz) in CDCl 3 and in the mixture of CDCl 3 + C 6 D 6 1 : 1. Chemical shifts (in ppm, δ-scale) were referenced to tetramethylsilane (in 1 H NMR spectra) and/or to signal of solvent (δ(CDCl 3 ) = 77.0 in 13 C NMR spectra); coupling constants (J) are given in Hz. The complete structural assignment of hydrogen and carbon signals was achieved combining 1D proton and carbon NMR spectra with 2D-H,H-COSY, 2D-H,H-ROESY, 2D-H,C-HSQC and 2D-H,C-HMBC spectra. 600 nm (OD 600 ) of bacterial cultures was determined spectrophotometrically using a Beckman DU-65.
The microtitre plate bioassay
Aqueous extracts of tested samples were resuspended to a concentration of 50 mg ml − 1 in distilled water. Ethanol and ethyl acetate extracts were resuspended to the same concentration in ethanol, to allow homogeneous dispersion of the sample in water. Each extract was bioassayed against B. subtilis (ATCC 6051); S. aureus (ATCC 12600); E. coli (ATCC 11775) and K. pneumoniae (ATCC 13883). For each bacterium, resuspended extract (100 μl) was serially diluted 50% with sterile distilled water (100 μl) using a sterile 96-well microtitre plate. Neomycin (100 μg ml − 1 ) was serially diluted 50% with sterile distilled water (100 μl) as a positive control for each test bacterium. Extract and bacteria-free negative controls were also included for each bacterium. Bacterial suspension cultures were diluted 1 : 100 with sterile MH broth, and 100 μl of each sample were added to wells containing the test and control solutions, respectively. The plate was covered and incubated overnight at 37°C. To determine antibacterial activity, 40 μl of piodonitrotetrazolium (INT) violet (Sigma), dissolved in sterile distilled water to 0.2 mg ml − 1 , were added to each well. The plate was incubated for 30 min at 37°C. The MIC was taken to be the lowest concentration of plant extract in wells in which colour change did not occur.
Bioautographic assay
The plates were developed in a solvent system of hexane-ethyl acetate (3 : 2) and air-dried. The reference plate was subsequently sprayed with 0.5% p-anisaldehyde stain and heated for 10 min at 110°C. The test plate was allowed to dry overnight prior to being sprayed with a concentrated suspension of actively growing S. aureus cells. This was prepared with bacterial cells from liquid culture collected by centrifugation (Beckman L7-55 Ultracentrifuge) at 3000 g for 10 min at 18°C. The resultant pellet was resuspended in sterile MH broth to yield an optical density of approximately 0.8 (600 nm). The inoculated plate was incubated overnight at 37°C in 100% relative humidity. To detect antibacterial activity, the plate was sprayed with a 2 mg ml 
Results and discussion
The active compound present in fraction E from the VLC was identified as 3-oxo-friedelan-20α-oic acid and is more commonly known as maytenonic acid. This compound was first isolated from M. senegalensis by Abraham et al. (1971) . The stereochemistry of the carboxylic acid at C-20 was not settled, and based on mass spectral fragmentation data, its orientation was proposed as syn with the 27-Me. Later this compound was isolated from the roots of Plenckia polpunea and named polpunonic acid which was reported to exhibit antibacterial and antimitotic activity (Monache et al., 1972) . The stereochemistry of the carboxylic acid at C-20 was described as being α by subjecting its 3-hydroxy-29-carboxylic acid methyl ester to the friedelane-oleane rearrangement to obtain the 18,29-lactone (Monache et al., 1972) .
Our HRMS data determined the molecular mass as 457.3694 which corresponds well with 457.3682 which is the molecular ion mass of formula C 30 H 49 0 3 (M + 1). The molecular formula C 30 H 48 0 3 corresponds to 3-oxo-friedelan-20α-oic acid (Scheme 1). The structure was then confirmed by the NMR spectra. The obtained 1 H and 13 C NMR parameters are summarized in Table 1 . Our 13 C NMR data agrees well with those described in the literature (Ramaiah et al., 1984) except with the assignment of Me-25, Me-26 and Me-27 signals, which needs to be interchanged (Table 1) on the basis of our 2D-H,C-HMBC spectrum. Ramaiah et al. (1984) only described Me-signals and H-4α proton NMR data. We can now present a complete set of proton chemical shifts (Table 1) extracted from homo-and heteronuclear 2D-NMR spectra. The coupling constants J(H,H) could be obtained only for protons of rings A and E (Fig. 1a,b ) since other proton multiplets are heavily overlapped. Vicinal and long-range J(H,H) confirm a chair-form of rings A and E. The 1 H NMR spectrum measured in CDCl 3 shows an overlap of three methyl signals at δ ∼ 0.87. Therefore the additional set of NMR spectra was taken in the mixture of CDCl 3 + C 6 D 6 (1 : 1) where a good resolution of all methyl groups was achieved. The complete assignment of all 1 H and 13 C signals in this solvent mixture is also given in Table 1 .
The configuration at C-20 with COOH in α-position and methyl group in β-position followed from the observed NOE contacts between (Fig. 1c) together with the absence of NOE between Me-30 and Me-27 (which should be observed in the case of opposite configuration at C-20).
Antibacterial activity in members of the Celastraceae is attributed to a group of secondary compounds, the nortriterpene quinone methides with a friedo-oleane skeleton . Several other compounds exhibiting antibacterial activity have been isolated from M. canariensis (González et al., 1996; Herrera et al., 1996) , M. catingarum , M scutiodes (González et al., 1999) , M. heterophylla and M. arbutifolia (Orabi et al., 2001) . Antibacterial testing showed that maytenonic acid isolated from M. senegalensis is active in inhibiting bacterial growth although this activity is less than that observed by the neomycin standard (Table 2 ). There are however many other compounds present in the root bark of M. senegalensis which also exhibit antibacterial activity and need to be characterized. This work has however enabled a complete set of chemical data for maytenonic acid to be reported and the previously published structure of this compound to be corrected. 
